- Home
- INZY vs LANV Comparison
INZY vs LANV Comparison
Compare INZY & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- LANV
- Stock Information
- Founded
- INZY 2015
- LANV 2015
- Country
- INZY United States
- LANV China
- Employees
- INZY N/A
- LANV N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- INZY Health Care
- LANV Finance
- Exchange
- INZY Nasdaq
- LANV Nasdaq
- Market Cap
- INZY 256.3M
- LANV 258.1M
- IPO Year
- INZY 2020
- LANV N/A
- Fundamental
- Price
- INZY N/A
- LANV $2.24
- Analyst Decision
- INZY Buy
- LANV
- Analyst Count
- INZY 9
- LANV 0
- Target Price
- INZY $15.22
- LANV N/A
- AVG Volume (30 Days)
- INZY 989.2K
- LANV 38.8K
- Earning Date
- INZY 08-05-2025
- LANV 08-25-2025
- Dividend Yield
- INZY N/A
- LANV N/A
- EPS Growth
- INZY N/A
- LANV N/A
- EPS
- INZY N/A
- LANV N/A
- Revenue
- INZY N/A
- LANV $340,211,202.00
- Revenue This Year
- INZY N/A
- LANV $11.74
- Revenue Next Year
- INZY N/A
- LANV $11.11
- P/E Ratio
- INZY N/A
- LANV N/A
- Revenue Growth
- INZY N/A
- LANV N/A
- 52 Week Low
- INZY $0.72
- LANV $0.91
- 52 Week High
- INZY $6.24
- LANV $2.69
- Technical
- Relative Strength Index (RSI)
- INZY 82.67
- LANV 53.13
- Support Level
- INZY $3.94
- LANV $2.00
- Resistance Level
- INZY $3.97
- LANV $2.51
- Average True Range (ATR)
- INZY 0.01
- LANV 0.15
- MACD
- INZY -0.08
- LANV 0.02
- Stochastic Oscillator
- INZY 100.00
- LANV 37.25
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.